Litcius/Paper detail

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial

Virginie Westeel, Pascal Foucher, Arnaud Scherpereel, J. Domas, Philippe Girard, Jean Trédaniel, Marie Wislez, Patrick Dumont, Élisabeth Quoix, Olivier Raffy, Denis Braun, Marc Derollez, François Goupil, Jacques Hermann, Etienne Devin, H Barbieux, Éric Pichon, D. Debieuvre, G. Ozenne, Jean‐François Muir, S. Dehette, J. Virally, M Grivaux, François Lebargy, Pierre-Jean Souquet, Faraj Al Freijat, Nicolas Girard, Emmanuel Courau, R. Azarian, M. Farny, Jean-Paul Duhamel, Alexandra Langlais, Franck Morin, B. Milleron, Gérard Zalcman, Fabrice Barlési

2022The Lancet Oncology64 citationsDOI

Topics & Concepts

MedicineClinical endpointLung cancerPopulationSurgeryAdenocarcinomaStage (stratigraphy)Randomized controlled trialInternal medicineCancerBiologyPaleontologyEnvironmental healthLung Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical ImagingAdvances in Oncology and Radiotherapy
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial | Litcius